Skip to main content

Sodium Fluoride Paste

Dosage form: dental paste
Drug class: Mouth and throat products

Medically reviewed by Drugs.com. Last updated on Jun 1, 2021.

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. Read further information about unapproved drugs.

Rx Only

1.1% Sodium fluoride
Prescription Strength Toothpaste

Sodium Fluoride Paste Description

Self-topical neutral fluoride dentifrice containing 1.1% (w/w) sodium fluoride for use as a dental caries preventive in adults and pediatric patients.

Active Ingredient

Sodium Fluoride 1.1% (w/w)

Inactive Ingredients

Flavor, glycerin, hydrated silica, purified water, sodium benzoate, sodium lauryl sulfate, sodium saccharin, sorbitol, tetrasodium pyrophosphate, titanium dioxide, xanthan gum. This product also contains flavor, FD&C Blue #1 (Spearmint only), FD&C Red #40 (Fruity only)

Sodium Fluoride Paste - Clinical Pharmacology

Frequent topical applications to the teeth with preparations having a relatively high fluoride content increase tooth resistance to acid dissolution and enhance penetration of the fluoride ion into tooth enamel.

Indications and Usage for Sodium Fluoride Paste

A dental caries preventive; for once daily self-applied topical use. It is well established that 1.1% sodium fluoride is safe and extraordinarily effective as a caries preventive when applied frequently with mouthpiece applicators.1-4 Sodium Fluoride 5000 ppm 1.1% sodium fluoride in a squeeze-tube is easily applied onto a toothbrush. This prescription should be used once daily in place of your regular toothpaste, unless otherwise instructed by your dental professional. May be used in areas where drinking water is fluoridated since topical fluoride cannot produce fluorosis. (See WARNINGS for exception.)

Contraindications

Do not use in pediatric patients under age 6 years unless recommended by a dentist or physician.

Warnings

Prolonged daily ingestion may result in various degrees of dental fluorosis in pediatric patients under age 6 years, especially if the water fluoridation exceeds 0.6 ppm, since younger pediatric patients frequently cannot perform the brushing process without significant swallowing. Use in pediatric patients under age 6 years requires special supervision to prevent repeated swallowing of toothpaste, which could cause dental fluorosis. Pediatric patients under age 12 should be supervised in the use of this product. Read directions carefully before using.

Keep out of reach of infants and children.

Precautions

General

Not for systemic treatment. DO NOT SWALLOW.

Carcinogenesis, Mutagenesis, Impairment of Fertility

In a study conducted in rodents, no carcinogenesis was found in male and female mice and female rats treated with fluoride at dose levels ranging from 4.1 to 9.1 mg/kg of body weight. Equivocal evidence of carcinogenesis was reported in male rats treated with 2.5 and 4.1 mg/kg of body weight.

In a second study, no carcinogenesis was observed in rats, males or females, treated with fluoride up to 11.3 mg/kg of body weight. Epidemiological data provide no credible evidence for an association between fluoride, either naturally occurring or added to drinking water, and risk of human cancer.

Fluoride ion is not mutagenic in standard bacterial systems. It has been shown that fluoride ion has potential to induce chromosome aberrations in cultured human and rodent cells at doses much higher than those to which humans are exposed. In vivo data are conflicting. Some studies report chromosome damage in rodents, while other studies using similar protocols report negative results.

Potential adverse reproductive effects of fluoride exposure in humans have not been adequately evaluated. Adverse effects on reproduction were reported for rats, mice, fox, and cattle exposed to 100 ppm or greater concentrations of fluoride in their diet or drinking water. Other studies conducted in rats demonstrated that lower concentrations of fluoride (5 mg/kg of body weight) did not result in impaired fertility and reproductive capabilities.

Pregnancy

Teratogenic Effects

Pregnancy Category B

It has been shown that fluoride crosses the placenta of rats, but only 0.01% of the amount administered is incorporated in fetal tissue. Animal studies (rats, mice, rabbits) have shown that fluoride is not a teratogen. Maternal exposure to 12.2 mg fluoride/kg of body weight (rats) or 13.1 mg/kg of body weight (rabbits) did not affect the litter size or fetal weight and did not increase the frequency of skeletal or visceral malformations. There are no adequate and well-controlled studies in pregnant women.

However, epidemiological studies conducted in areas with high levels of naturally fluoridated water showed no increase in birth defects. Heavy exposure to fluoride during in utero development may result in skeletal fluorosis, which becomes evident in childhood.

Nursing Mothers

It is not known if fluoride is excreted in human milk. However, many drugs are excreted in milk, and caution should be exercised when products containing fluoride are administered to a nursing woman. Reduced milk production was reported in farm-raised fox when the animals were fed a diet containing a high concentration of fluoride (98-137 mg/kg of body weight). No adverse effects on parturition, lactation, or offspring were seen in rats administered fluoride up to 5 mg/kg of body weight.

Pediatric Use

The use of Sodium Fluoride 5000 ppm in pediatric age groups 6 to 16 years as a caries preventive is supported by pioneering clinical studies with 1.1% sodium fluoride gels in mouth trays in students age 11-14 years conducted by Englander et al.2-4 Safety and effectiveness in pediatric patients below the age of 6 years have not been established. Please refer to the CONTRAINDICATIONS and WARNINGS sections.

Adverse Reactions

Allergic reactions and other idiosyncrasies have been rarely reported.

To report SUSPECTED ADVERSE REACTIONS, contact Westminster Pharmaceuticals, LLC at 1-844-221-7294 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Overdosage

Accidental ingestion of large amounts of fluoride may result in acute burning in the mouth and sore tongue. Nausea, vomiting, and diarrhea may occur soon after ingestion (within 30 minutes) and are accompanied by salivation, hematemesis, and epigastric cramping abdominal pain. These symptoms may persist for 24 hours. If less than 5 mg fluoride/kg body weight (i.e., less than 2.3 mg fluoride/lb body weight) has been ingested, give calcium (e.g., milk) orally to relieve gastrointestinal symptoms and observe for a few hours. If more than 5 mg fluoride/kg body weight (i.e., more than 2.3 mg fluoride/lb body weight) have been ingested, induce vomiting, give orally soluble calcium (e.g., milk, 5% calcium gluconate or calcium lactate solution) and immediately seek medical assistance. For accidental ingestion of more than 15 mg fluoride/kg of body weight (i.e., more than 6.9 mg fluoride/lb body weight), induce vomiting and admit immediately to a hospital facility.

A treatment dose (a thin ribbon) of Sodium Fluoride 5000 ppm contains 2.5 mg fluoride. A 3.4 FL OZ tube (100 ml) contains approximately 605 mg fluoride.

Sodium Fluoride Paste Dosage and Administration

Follow these instructions unless otherwise instructed by your dental professional:

  1. Adults and pediatric patients 6 years of age or older, apply a thin ribbon of Sodium Fluoride 5000 ppm to a toothbrush. Brush teeth thoroughly once daily for at least two minutes, preferably at bedtime, in place of your regular toothpaste.
  2. After use, adults expectorate. For best results, do not eat, drink, or rinse for 30 minutes. Pediatric patients, age 6-16, expectorate after use and rinse mouth thoroughly.

How Supplied

3.4 FL OZ (100ml) NET WT. Tube NDC 69367-311-01 Spearmint
3.4 FL OZ (100ml) NET WT. Tube NDC 69367-312-01 Fruity

STORAGE

Store at Controlled Room Temperature, 20° -25°C (68°-77°F).

REFERENCES

  1. Accepted Dental Therapeutics, Ed. 40, ADA, Chicago. P. 405-407, 1984.
  2. Englander, HR, Keyes et al:JADA 75: 638-644, 1967.
  3. Englander, HR, et al:JADA 78: 783-787, 1969.
  4. Englander, HR, et al:JADA 83: 354-358, 1971.

Manufactured for:
Westminster Pharmaceuticals, LLC
Nashville, TN 37217
Rev. 03/21

PRINCIPAL DISPLAY PANEL - 100 mL Tube Carton

SPEARMINT
NDC 69367-311-01
Rx Only

Sodium Fluoride 5000 ppm
1.1% Sodium Fluoride Prescription Strength Toothpaste

3.4 FL OZ (100 mL)

Westminster
Pharmaceuticals

PRINCIPAL DISPLAY PANEL - 100 mL Tube Carton - FRUITY

FRUITY
NDC 69367-312-01
Rx Only

Sodium Fluoride 5000 ppm
1.1% Sodium Fluoride Prescription Strength Toothpaste

3.4 FL OZ (100 mL)

Westminster
Pharmaceuticals

SODIUM FLUORIDE 5000 PPM
Sodium Fluoride Paste
Product Information
Product Type HUMAN PRESCRIPTION DRUG LABEL Item Code (Source) NDC:69367-311
Route of Administration DENTAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
SODIUM FLUORIDE (FLUORIDE ION) FLUORIDE ION 6 mg in 1 mL
Inactive Ingredients
Ingredient Name Strength
WATER
SODIUM BENZOATE
SACCHARIN SODIUM
TITANIUM DIOXIDE
SODIUM PYROPHOSPHATE
SORBITOL
FD&C BLUE NO. 1
HYDRATED SILICA
GLYCERIN
XANTHAN GUM
SODIUM LAURYL SULFATE
Product Characteristics
Color BLUE Score
Shape Size
Flavor SPEARMINT Imprint Code
Contains
Packaging
# Item Code Package Description
1 NDC:69367-311-01 100 mL in 1 TUBE
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
UNAPPROVED DRUG OTHER 06/16/2021
SODIUM FLUORIDE 5000 PPM
Sodium Fluoride Paste
Product Information
Product Type HUMAN PRESCRIPTION DRUG LABEL Item Code (Source) NDC:69367-312
Route of Administration DENTAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
SODIUM FLUORIDE (FLUORIDE ION) FLUORIDE ION 6 mg in 1 mL
Inactive Ingredients
Ingredient Name Strength
WATER
SODIUM BENZOATE
SACCHARIN SODIUM
TITANIUM DIOXIDE
SODIUM PYROPHOSPHATE
SORBITOL
FD&C RED NO. 40
HYDRATED SILICA
GLYCERIN
XANTHAN GUM
SODIUM LAURYL SULFATE
Product Characteristics
Color PINK Score
Shape Size
Flavor FRUIT Imprint Code
Contains
Packaging
# Item Code Package Description
1 NDC:69367-312-01 100 mL in 1 TUBE
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
UNAPPROVED DRUG OTHER 06/16/2021
Labeler - Westminster Pharmaceuticals, LLC (079516651)
Westminster Pharmaceuticals, LLC